Clinical Trial Detail

NCT ID NCT01765543
Title A Pharmacokinetics Study to Investigate the Effect of Rifampin on Vemurafenib in Patients With BRAFV600 Mutation-Positive Metastatic Malignancy
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Hoffmann-La Roche
Indications

Advanced Solid Tumor

melanoma

Therapies

Rifampin + Vemurafenib

Age Groups: adult

Additional content available in CKB BOOST